Focal type in-stent restenosis after drug-eluting stent implantation treated by cutting balloon angioplasty versus sirolimus-eluting stent.

Trial Profile

Focal type in-stent restenosis after drug-eluting stent implantation treated by cutting balloon angioplasty versus sirolimus-eluting stent.

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Aug 2012

At a glance

  • Drugs Sirolimus (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia
  • Focus Therapeutic Use
  • Acronyms FOCUS
  • Most Recent Events

    • 07 Aug 2012 Actual end date (1 Mar 2011) added as reported by ClinicalTrials.gov record.
    • 01 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 06 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top